Acetazolamide (Compound)

Synonyms:acetazolamide, 59-66-5, Diamox, Acetamox, Glaupax, N-(5-Sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide, Defiltran, Nephramide, Edemox, Acetazolamid, Phonurit, Diacarb, Donmox, Didoc, Cidamex, Diluran, Diuriwas, Dehydratin, Diuramid, Diutazol, Duiramid, Eumicton, Natrionex, Nephramid, Diakarb, Fonurit, Glupax, Vetamox, SK-acetazolamide, 5-Acetamido-1,3,4-thiadiazole-2-sulfonamide, Acetazolamidum, Acetazoleamide, Acetozalamide, Diureticum-holzinger, Acetamidothiadiazolesulfonamide, Acetazolamida, 4-Diamox, Acetamide, N-[5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl]-, Carbonic Anhydrase Inhibitor No. 6063, 2-Acetylamino-1,3,4-thiadiazole-5-sulfonamide, N-[5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide, Atenezo, 2-Acetamido-5-sulfonamido-1,3,4-thiadiazole, Carbonic anhydrase inhibitor 6063, NSC 145177, 1,3,4-Thiadiazole-2-sulfonamide, 5-acetamido-, N-(5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl)acetamide, 5-Acetamide-1,3,4-thiadiazole-2-sulfonamide, CHEMBL20, Diamox (TN), NSC-145177, MLS000028435, O3FX965V0I, Acetamide, N-(5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl)-, DTXSID7022544, CHEBI:27690, Acetamide, N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)-, CAS-59-66-5, NCGC00015074-10, Acetazolamine, Atenezol, Glaumox, SMR000058394, Diamox Sequels, 5-acetylamino-1,3,4-thiadiazole-2-sulfonamide, L 579486, Acetazolamidum [INN-Latin], DTXCID002544, Acetazolamida [INN-Spanish], N-[5-(aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide, CCRIS 5811, Acetazolamide (AAZ), HSDB 3002, SR-01000000065, EINECS 200-440-5, MFCD00003105, UNII-O3FX965V0I, AI3-52458, Prestwick_4, 1azm, 1yda, 1ydb, 1ydd, 1zsb, 2xtk, 3czv, 3ucj, Acetazolamide, 5, Acetazolamide [USP:INN:BAN:JAN], Acerazolamide, AAZ, Acetazolamide, AAZ, Acetazolamide, AZA, Acetazolamide, AZM, Spectrum_000018, 1jd0, 2h4n, 2uy4, 3dc3, 3hs4, 3ml5, 4g0c, Opera_ID_288, AZA2, Prestwick0_000003, Prestwick1_000003, Prestwick2_000003, Prestwick3_000003, Spectrum2_000082, Spectrum3_000284, Spectrum4_000139, Spectrum5_000738, Lopac-A-6011, ACETAZOLAMIDE [MI], A 6011, ACETAZOLAMIDE [INN], ACETAZOLAMIDE [JAN], ACETAZOLAMIDE [HSDB], Lopac0_000039, SCHEMBL23219, ACETAZOLAMIDE [VANDF], BSPBio_000005, BSPBio_001788, KBioGR_000558, KBioSS_000358, MLS001148438, ACETAZOLAMIDE [MART.], BIDD:GT0643, DivK1c_000017, SPECTRUM1500102, N-(5-Sulfamoyl-[1,3,4]thiadiazol-2-yl)-acetamide, SPBio_000004, SPBio_001926, ACETAZOLAMIDE [USP-RS], ACETAZOLAMIDE [WHO-DD], ACETAZOLAMIDE [WHO-IP], BPBio1_000007, GTPL6792, (non-d)Acetazolamide-13C2-d3, Acetazolamide, >=99%, powder, SCHEMBL11049053, BDBM10880, BZKPWHYZMXOIDC-UHFFFAOYSA-, HMS500A19, KBio1_000017, KBio2_000358, KBio2_002926, KBio2_005494, KBio3_001288, Acetazolamide (JP17/USP/INN), AMY3289, N-[5-(Aminosulfonyl)-1,3,4-thiadiozol-2-yl]-Acetamide, Acetazolamide, analytical standard, NINDS_000017, HMS1568A07, HMS1920A05, HMS2091G05, HMS2095A07, HMS2232G23, HMS3259I13, HMS3260G19, HMS3370P01, HMS3712A07, HMS3744A21, Pharmakon1600-01500102, WLN: T5NN DSJ CSZW EMV1, ACETAZOLAMIDE [EP IMPURITY], ACETAZOLAMIDE [ORANGE BOOK], ALBB-023617, BCP29616, HY-B0782, ACETAZOLAMIDE [EP MONOGRAPH], Tox21_110078, Tox21_201559, Tox21_302773, Tox21_500039, ACETAZOLAMIDE [USP MONOGRAPH], CCG-38900, NSC145177, NSC755854, s4506, ACETAZOLAMIDUM [WHO-IP LATIN], AKOS000715163, Tox21_110078_1, CS-3568, DB00819, LP00039, NC00491, NSC-755854, SDCCGSBI-0050028.P005, IDI1_000017, NCGC00015074-01, NCGC00015074-02, NCGC00015074-03, NCGC00015074-04, NCGC00015074-05, NCGC00015074-06, NCGC00015074-07, NCGC00015074-08, NCGC00015074-09, NCGC00015074-11, NCGC00015074-12, NCGC00015074-14, NCGC00015074-15, NCGC00015074-17, NCGC00015074-22, NCGC00023455-03, NCGC00023455-04, NCGC00023455-05, NCGC00023455-06, NCGC00023455-07, NCGC00256374-01, NCGC00259108-01, NCGC00260724-01, AC-12779, AS-13169, SBI-0050028.P004, 2-Acetamido-5-sulfonamido-1,4-thiadiazole, 5-Acetamide-1,4-thiadiazole-2-sulfonamide, DB-053437, 5-Acetamido-1,3,4-thiadiazol-2-sulfonamide, AB00051906, EU-0100039, 1,4-Thiadiazole-2-sulfonamide, 5-acetamido-, C06805, D00218, D88526, EN300-119493, AB00051906_15, A832415, N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)ethanamide, Q413690, Q-200579, Q-200580, SR-01000000065-2, SR-01000000065-4, SR-01000000065-6, BRD-K43457670-001-22-9, BRD-K43457670-001-26-0, Z277559108, (1z)-N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)ethanimidic acid, Acetazolamide, European Pharmacopoeia (EP) Reference Standard, Acetazolamide, United States Pharmacopeia (USP) Reference Standard, N - (5 - Sulfamoyl - 1,3, 4 - thiadiazol - 2 - yl) acetamide, Acetazolamide for system suitability, European Pharmacopoeia (EP) Reference Standard, Acetazolamide, Pharmaceutical Secondary Standard; Certified Reference Material, 124442-28-0

Pubchem:PUBCHEM:1986

Id:39979edf-6bbb-5d0a-b990-4f8d7163e2ab

Description:nan